1. Home
  2. RGEN vs FRHC Comparison

RGEN vs FRHC Comparison

Compare RGEN & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • FRHC
  • Stock Information
  • Founded
  • RGEN 1981
  • FRHC 1981
  • Country
  • RGEN United States
  • FRHC United States
  • Employees
  • RGEN N/A
  • FRHC N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • FRHC Investment Bankers/Brokers/Service
  • Sector
  • RGEN Health Care
  • FRHC Finance
  • Exchange
  • RGEN Nasdaq
  • FRHC Nasdaq
  • Market Cap
  • RGEN 8.0B
  • FRHC 7.8B
  • IPO Year
  • RGEN N/A
  • FRHC N/A
  • Fundamental
  • Price
  • RGEN $126.50
  • FRHC $176.00
  • Analyst Decision
  • RGEN Buy
  • FRHC
  • Analyst Count
  • RGEN 12
  • FRHC 0
  • Target Price
  • RGEN $172.67
  • FRHC N/A
  • AVG Volume (30 Days)
  • RGEN 815.5K
  • FRHC 78.8K
  • Earning Date
  • RGEN 04-29-2025
  • FRHC 06-13-2025
  • Dividend Yield
  • RGEN N/A
  • FRHC N/A
  • EPS Growth
  • RGEN N/A
  • FRHC N/A
  • EPS
  • RGEN N/A
  • FRHC 5.36
  • Revenue
  • RGEN $650,429,000.00
  • FRHC $1,578,152,000.00
  • Revenue This Year
  • RGEN $13.93
  • FRHC N/A
  • Revenue Next Year
  • RGEN $14.35
  • FRHC N/A
  • P/E Ratio
  • RGEN N/A
  • FRHC $31.78
  • Revenue Growth
  • RGEN 4.88
  • FRHC 79.07
  • 52 Week Low
  • RGEN $102.97
  • FRHC $68.82
  • 52 Week High
  • RGEN $182.52
  • FRHC $164.83
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.61
  • FRHC 80.93
  • Support Level
  • RGEN $123.10
  • FRHC $138.99
  • Resistance Level
  • RGEN $135.47
  • FRHC $157.99
  • Average True Range (ATR)
  • RGEN 6.98
  • FRHC 4.75
  • MACD
  • RGEN -0.97
  • FRHC 2.77
  • Stochastic Oscillator
  • RGEN 25.20
  • FRHC 87.81

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About FRHC Freedom Holding Corp.

Freedom Holding Corp is a holding company with its subsidiary it is engaged in securities brokerage, securities dealing for customers and account, market-making activities, investment research, investment counseling, investment banking services, retail and commercial banking, insurance products, payment services, and information processing services. It acts as a professional participant through its subsidiaries on the Kazakhstan Stock Exchange (KASE), Moscow Exchange (MOEX), Saint-Petersburg Exchange (SPB), the Ukrainian Exchange, the Uzbek Republican Currency Exchange (UZCE), and the Republican Stock Exchange of Tashkent (UZSE). Its segments are Brokerage, Banking, Insurance, and Others.

Share on Social Networks: